Project Switch: Docetaxel as a potential synthetic control in metastatic non-small cell lung cancer (mNSCLC) trials.

被引：0
|
作者：
Menefee, Michael E. [1 ]
Gong, Yutao [1 ]
Mishra-Kalyani, Pallavi Shruti [1 ]
Sridhara, Rajeshwari [1 ]
Kanapuru, Bindu [1 ]
Blumenthal, Gideon Michael [1 ]
Pazdur, Richard [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9105
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Docetaxel (taxotere) in the treatment of non-small cell lung cancer
    Georgoulias, V
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (08) : 869 - 877
  • [32] Metastatic Non-Small Cell Lung Cancer to the Small Bowel
    Levy, Sara
    Shroff, Sagar
    Qayed, Emad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S421 - S421
  • [33] LKB1 Mutations in Metastatic Non-Small Cell Lung Cancer (mNSCLC): Prognostic Value in the Real World
    Golozar, A.
    Collins, J.
    Fraeman, K.
    Nordstrom, B.
    Mcewen, R.
    Shire, N.
    Higgs, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S223 - S224
  • [34] Economic Burden of Metastatic Non-Small Cell Lung Cancer (mNSCLC) in a Large United States (US) Claims Database
    Chou, E.
    Ganti, A. K.
    Katranji, K.
    Cotarla, I.
    Sharma, C.
    Miao, B.
    Garg, M.
    Seal, B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S11 - S12
  • [35] Therapy of Metastatic Non-small Cell Lung Cancer
    Reinmuth, N.
    Groeschel, A.
    Schumann, C.
    Sebastian, M.
    Wiewrodt, R.
    Reck, M.
    PNEUMOLOGIE, 2016, 70 (09): : 567 - 578
  • [36] Immunotherapy of metastatic non-small cell lung cancer
    Sackmann, Sandra
    Ogundele, Samuel
    Ukena, Dieter
    PNEUMOLOGE, 2019, 16 (06): : 353 - 365
  • [37] Chemotherapy for metastatic non-small cell lung cancer
    Pérol, M
    Moro-Sibilot, D
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (06) : S131 - S136
  • [38] PATIENT CHARACTERISTICS AND FIRST LINE TREATMENTS AMONG MEDICARE PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC)
    Ejzykowicz, F.
    Chen, X.
    Petrilla, A.
    Schroeder, A.
    Dietz, K.
    Agatep, B.
    Burke, T.
    Lopes, G.
    VALUE IN HEALTH, 2020, 23 : S25 - S25
  • [39] Phase II Trials of Imatinib Mesylate and Docetaxel in Patients with Metastatic Non-small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma
    Tsao, Anne S.
    Liu, Suyu
    Fujimoto, Junya
    Wistuba, Ignacio I.
    Lee, J. Jack
    Marom, Edith M.
    Charnsangavej, Chusilp
    Fossella, Frank V.
    Tran, Hai T.
    Blumenschein, George R.
    Papadimitrakopoulou, Vassiliki
    Kies, Merrill S.
    Hong, Waun K.
    Stewart, David J.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (12) : 2104 - 2111
  • [40] Prediction of the efficacy of nivolumab using resting energy expenditure in metastatic non-small cell lung cancer (mNSCLC) patients
    Gervais, Claire
    Boudou-Rouquette, Pascaline
    Jouinot, Anne
    Chapron, Jeanne
    Arrondeau, Jennifer
    Alifano, Marco
    Giraud, Frederique
    Huillard, Olivier
    Alexandre, Jerome
    Vazeille, Clara
    Durand, Jean-Philippe
    Leroy, Karen
    Revel, Marie-Pierre
    de Bandt, Jean-Pascal
    Cynober, Luc
    Damotte, Diane
    Lupo-Mansuet, Audrey
    Goldwasser, Francois
    CANCER RESEARCH, 2018, 78 (13)
12345